However, although p-tau levels are high in the brain of Alzheimer’s disease patients, CSF p-tau levels were found to be weakly associated with the pathological changes indicative of neurofibrillary tangles in the brain of Alzheimer’s disease patients [120,124]. This evidence concerns the gene MAPT and Alzheimer disease.